CC
SPRY icon

Clearline Capital’s ARS Pharmaceuticals SPRY Stock Holding History

Clearline Capital’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-271,678
Closed -$1.03M – 125
2023
Q3 		$1.03M Buy
271,678
+210,576
+345% +$796K 0.09% 99
2023
Q2 		$409K Buy
+61,102
New +$409K 0.02% 102